理解临床试验的可实施性:一项实用综述与概念图
BACKGROUND: The translation of evidence from clinical trials into practice is complex. One approach to facilitating this translation is to consider the 'implementability' of trials as they are designed and conducted.…
要点
- 可实施性指晚期临床试验设计、执行和报告特征对证据落地能力的影响。
- 概念图含38个概念,覆盖有效性、相关性、可用性三个维度。
核心结论
- 概念图为试验者提供工具,系统思考提升试验可实施性的实践行动领域。
- 未来需验证概念与可实施性关联强度及干预措施效果。
研究设计与样本
- 实用文献综述,纳入2009年后发表的英文文献,涉及晚期临床试验设计、实施和报告。
- 由澳大利亚临床试验联盟组织,经专家参考组和滚雪球检索(2019年5月)形成概念图。
主要发现
- 最终概念图含38个概念,覆盖有效性、相关性和可用性三个维度,贯穿设计、实施和报告。
- 概念来源于实施科学、消费者参与、实用试验、报告、研究浪费等领域。
临床怎么用
- 试验者可在设计、实施和报告阶段参照概念图,识别提升可实施性的行动点。
- 澳大利亚临床试验联盟将据此制定针对本国试验者的指导。
局限性
- 概念与可实施性之间的关联强度尚未验证。
- 针对各概念的措施有效性有待研究。
- 本综述不包含健康相关结局,未在PROSPERO注册。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The translation of evidence from clinical trials into practice is complex. One approach to facilitating this translation is to consider the 'implementability' of trials as they are designed and conducted. Implementability of trials refers to characteristics of the design, execution and reporting of a late-phase clinical trial that can influence the capacity for the evidence generated by that trial to be implemented. On behalf of the Australian Clinical Trials Alliance (ACTA), the national peak body representing networks of clinician researchers conducting investigator-initiated clinical trials, we conducted a pragmatic literature review to develop a concept map of implementability. METHODS: Documents were included in the review if they related to the design, conduct and reporting of late-phase clinical trials; described factors that increased or decreased the capacity of trials to be implemented; and were published after 2009 in English. Eligible documents included systematic reviews, guidance documents, tools or primary studies (if other designs were not available). With an expert reference group, we developed a preliminary concept map and conducted a snowballing search based on known relevant papers and websites of key organisations in May 2019. RESULTS: Sixty-five resources were included. A final map of 38 concepts was developed covering the domains of validity, relevance and usability across the design, conduct and reporting of a trial. The concepts drew on literature relating to implementation science, consumer engagement, pragmatic trials, reporting, research waste and other fields. No single resource addressed more than ten of the 38 concepts in the map. CONCLUSIONS: The concept map provides trialists with a tool to think through a range of areas in which practical action could enhance the implementability of their trials. Future work could validate the strength of the associations between the concepts identified and implementability of trials and investigate the effectiveness of steps to address each concept. ACTA will use this concept map to develop guidance for trialists in Australia. TRIAL REGISTRATION: This review did not include health-related outcomes and was therefore not eligible for registration in the PROSPERO register.
引用
- Cumpston MS, Webb SA, Middleton P, et al. Understanding implementability in clinical trials: a pragmatic review and concept map. Trials. 2021. PMID: 33771197. doi:10.1186/s13063-021-05185-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。